Recombinant human luteinizing hormone supplementation may improve embryo quality in in vitro fertilization/intracytoplasmic sperm injection cycles with gonadotropin-releasing hormone antagonist protocol

Journals Menu

Follow SCIRP

ISSN Print: 2160-8792
ISSN Online: 2160-8806
www.scirp.org/journal/ojog
E-mail: ojog@scirp.org

Citations h5-index & Ranking

"Recombinant human luteinizing hormone supplementation may improve embryo quality in in vitro fertilization/intracytoplasmic sperm injection cycles with gonadotropin-releasing hormone antagonist protocol"
written by Amir Wiser, Ariel Hourvitz, Yoav Yinon, Jacob Levron, Jehoshua Dor, Shai Elizur,
published by Open Journal of Obstetrics and Gynecology, Vol.1 No.2, 2011

has been cited by the following article(s):

[1]	The Effect of Recombinant LH Addition to Recombinant FSH on Assisted Reproductive Technologies Outcomes in Overweight and Obese Patients without …
	2020

[2]	Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged≥ 35 years: a randomized controlled trial
	Human Reproduction, 2015

[3]	Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist …
	Human Reproduction, 2015

[4]	Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted …
	2014

[5]	Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted …
	2014

[6]	Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis
	Reproductive Biology and Endocrinology, 2014

[1]	Improving Implantation Rate in 2nd ICSI Cycle through Ovarian Stimulation with FSH and LH in GNRH Antagonist Regimen Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics, 2021 DOI:10.1055/s-0041-1736306

[2]	Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged >=35 years: a randomized controlled trial Human Reproduction, 2015 DOI:10.1093/humrep/dev038

[3]	Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis Reproductive Biology and Endocrinology, 2014 DOI:10.1186/1477-7827-12-17

Follow SCIRP